The SURMOUNT trials with tirzepatide demonstrated weight loss exceeding 20% at the highest doses, substantially more than what orforglipron has achieved in Phase 3
Clinical trials showed modest results, and AOD-9604 was not pursued through full FDA drug approval
However, the new study leverages data from social media to capture a broader range of experiences from GLP-1 users, including semaglutide and tirzepatide, that are not yet fully explored in the pharmaceutical and nutrition industries
Not only will weight loss surgery ease the possibility of a life-threatening condition, but it will also increase the chances of a longer (and happier) life
Furthermore , the dedicated team at Get Thin MD is known for their unwavering commitment to providing top-notch customer service
This makes results more predictable and effective